Dr. Alexander Paul ,
-
Frequent migraines? New prevention studies may help guide choices
New migraine-prevention research adds to the evidence that some people do better with CGRP-targeting medicines, onabotulinumtoxinA, or older oral options. But the best choice still depends on migraine pattern, side effects, cost, and other health conditions.
-
ADHD Medications in 2026: What Telehealth Rules and Ongoing Stimulant Shortages Mean for Patients
Federal telehealth flexibilities for prescribing ADHD stimulants were extended through December 31, 2025, while medication shortages continue into 2026. Here’s what patients and families across the United States should know about access, insurance, and practical next steps.
-
Evaluating the Influence of Health Insurance on Patient Health Outcomes
Exploring how health insurance impacts patient health outcomes through comprehensive evaluation.
-
2025 Health Insurance Open Enrollment Guide: Coverage Options
Master the 2025 Health Insurance Open Enrollment with essential dates, plan options, and expert guidance to secure the best coverage for your family.
